Bellinger Andrew
CSO & CMO at VERV
- Sold, on record
- $4.1M
- Dollars the filings state
- Form 4 sales
- 6
- Latest Dec 1, 2022
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- VERVVerve Therapeutics, Inc.CSO & CMO
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale VERVUnusualDec 22, 2021 2021
Sold 15,000 shares at $38.70 ($580k)
Bellinger Andrew, Chief Scientific Officer
Sold 75% of holdings ($774k position)5,000 shares leftFirst sale on recordFiling
- 2 Form 4 sale VERVUnusualJul 13, 2022 +203 days
Sold 10,000 shares at $24.90 ($249k)
Bellinger Andrew, CSO & CMO
Sold 60.1% of holdings ($414k position)6,629 shares leftFiling
- 3 Form 4 sale VERVUnusualJul 20, 2022 +7 days
Sold 20,000 shares at $34.90 ($698k)
Bellinger Andrew, CSO & CMO
Sold 75.1% of holdings ($929k position)6,629 shares leftFiling
- 4 Form 4 sale VERVUnusualSep 23, 2022 +65 days
Sold 60,000 shares at $35.34 ($2.1M)
Bellinger Andrew, CSO & CMO
Sold 90.1% of holdings ($2.4M position)6,629 shares left4x usual sizeFiling
- 5 Form 4 sale VERVUnusualOct 28, 2022 +35 days
Sold 10,000 shares at $39.90 ($399k)
Bellinger Andrew, CSO & CMO
Sold 60.1% of holdings ($663k position)6,629 shares left0.6x usual sizeFiling
- 6 Form 4 sale VERVPlan not statedDec 1, 2022 +34 days
Sold 865 shares at $22.95 ($20k)
Bellinger Andrew, CSO & CMO
Sold 11.5% of holdings ($172k position)6,629 shares left0.1x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (6)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Dec 1, 2022 | Dec 2, 2022 | VERV | CSO & CMO | Form 4 sale | 865 | $20k | 11.5% | Plan not stated | SEC |
| Oct 28, 2022 | Nov 1, 2022 | VERV | CSO & CMO | Form 4 sale | 10,000 | $399k | 60.1% | Unusual | SEC |
| Sep 23, 2022 | Sep 27, 2022 | VERV | CSO & CMO | Form 4 sale | 60,000 | $2.1M | 90.1% | Unusual | SEC |
| Jul 20, 2022 | Jul 22, 2022 | VERV | CSO & CMO | Form 4 sale | 20,000 | $698k | 75.1% | Unusual | SEC |
| Jul 13, 2022 | Jul 15, 2022 | VERV | CSO & CMO | Form 4 sale | 10,000 | $249k | 60.1% | Unusual | SEC |
| Dec 22, 2021 | Dec 27, 2021 | VERV | Chief Scientific Officer | Form 4 sale | 15,000 | $580k | 75.0% | Unusual | SEC |